Back to Journals » Drug Design, Development and Therapy » Volume 9
Original Research
Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
17,950 | Dovepress* | 17,335+ | 1,075 | 18,410 | |
PubMed Central* | 615 | 199 | 814 | ||
Totals | 17,950 | 1,274 | 19,224 | ||
*Since 13 November 2015 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar